Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study

BACKGROUND: Although statins are the cornerstone of lipid management, hardly any of the existing studies on statin treatment of dyslipidemia in nephrotic syndrome (NS) addressed patient‐centered outcomes of cardiovascular events. OBJECTIVE: To evaluate whether statin treatment impacts the outcomes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Xinliang, Nie, Li, Liao, Yi, Liu, Zhihui, Zheng, Wanxiang, Qu, Xiaolong, Xu, Xiang, Qin, Haoran, Wang, Haidong, Liu, Jianping, He, Guoxiang, Jing, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314031/
https://www.ncbi.nlm.nih.gov/pubmed/35184315
http://dx.doi.org/10.1002/phar.2675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314031/
https://www.ncbi.nlm.nih.gov/pubmed/35184315
http://dx.doi.org/10.1002/phar.2675

Ejemplares similares